completes

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

LEHI, Utah, June 4, 2025 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering therapies inspired by genetic resilience, today…

8 hours ago
Cango Inc. Completes PRC Business Sale, Strengthens Board to Drive Global Bitcoin FocusCango Inc. Completes PRC Business Sale, Strengthens Board to Drive Global Bitcoin Focus

Cango Inc. Completes PRC Business Sale, Strengthens Board to Drive Global Bitcoin Focus

SHANGHAI, May 29, 2025 /PRNewswire/ -- Cango Inc. (NYSE: CANG) ("Cango" or the "Company"), a rapidly expanding leader in Bitcoin mining, has finalized…

2 days ago